U.A. Walker

845 total citations
21 papers, 572 citations indexed

About

U.A. Walker is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, U.A. Walker has authored 21 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 5 papers in Pathology and Forensic Medicine and 4 papers in Immunology. Recurrent topics in U.A. Walker's work include Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Sclerosis and Related Diseases (4 papers) and Histiocytic Disorders and Treatments (3 papers). U.A. Walker is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Sclerosis and Related Diseases (4 papers) and Histiocytic Disorders and Treatments (3 papers). U.A. Walker collaborates with scholars based in Switzerland, Germany and United States. U.A. Walker's co-authors include H. H. Peter, J. Keul, Ernst Jakob, Marco Matucci‐Cerinic, Carlos Müller, Jaap Fransen, Yannick Allanore, László Czirják, Gabriele Valentini and Alan Tyndall and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and Acta Neurologica Scandinavica.

In The Last Decade

U.A. Walker

18 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U.A. Walker Switzerland 10 318 138 123 113 99 21 572
Rebecca Matro United States 10 140 0.4× 37 0.3× 162 1.3× 40 0.4× 117 1.2× 19 530
Gemma Lepri Italy 17 375 1.2× 145 1.1× 94 0.8× 105 0.9× 14 0.1× 51 604
A Hartkamp Netherlands 14 85 0.3× 35 0.3× 168 1.4× 238 2.1× 77 0.8× 19 661
Tim Holbrook United Kingdom 9 92 0.3× 21 0.2× 142 1.2× 132 1.2× 31 0.3× 37 643
Peter Loughenbury United Kingdom 12 105 0.3× 56 0.4× 221 1.8× 225 2.0× 30 0.3× 40 582
Brian R. Kaye United States 9 88 0.3× 30 0.2× 125 1.0× 294 2.6× 69 0.7× 11 650
Rakan Bokhari Saudi Arabia 12 126 0.4× 45 0.3× 219 1.8× 98 0.9× 16 0.2× 35 662
Darren G. Gregory United States 15 86 0.3× 155 1.1× 101 0.8× 93 0.8× 14 0.1× 32 838
G R Struthers United Kingdom 15 65 0.2× 41 0.3× 105 0.9× 348 3.1× 63 0.6× 27 734
Kunlawat Thadanipon Thailand 14 78 0.2× 174 1.3× 54 0.4× 63 0.6× 38 0.4× 52 590

Countries citing papers authored by U.A. Walker

Since Specialization
Citations

This map shows the geographic impact of U.A. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U.A. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U.A. Walker more than expected).

Fields of papers citing papers by U.A. Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U.A. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U.A. Walker. The network helps show where U.A. Walker may publish in the future.

Co-authorship network of co-authors of U.A. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of U.A. Walker. A scholar is included among the top collaborators of U.A. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U.A. Walker. U.A. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lehmann, Julia, Stavros Giaglis, Diego Kyburz, Douglas Daoudlarian, & U.A. Walker. (2024). POS1206 ORIGIN AND DIAGNOSTIC POTENTIAL OF EXTRACELLULAR DNA IN RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 83. 740–740.
2.
Reichenbach, Stephan, et al.. (2021). Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis. Arthritis Research & Therapy. 23(1). 267–267. 4 indexed citations
3.
Jaeger, Veronika K., et al.. (2018). SAT0161 Influence of disease activity in rheumatoid arthritis on radiographic progression of concomitant interphalangeal joint osteoarthritis. Annals of the Rheumatic Diseases. 77. 941–941. 1 indexed citations
4.
Walker, U.A., Veronika K. Jaeger, Martin Banyai, et al.. (2017). FRI0369 Prospective evaluation of the capillaroscopic skin ulcer index (CSURI) in clinical practice. Annals of the Rheumatic Diseases. 76. 626–627. 1 indexed citations
5.
Kuemmerle‐Deschner, J. B., et al.. (2015). Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: results from beta-confident registry. Pediatric Rheumatology. 13(S1). 4 indexed citations
6.
Finckh, Axel, Ruediger B. Müeller, Jean Dudler, et al.. (2015). OP0166 Antibodies Against Periodontal Pathogens are not Associated with Joint Swelling or Autoimmunity Associated with RA in a Cohort of Healthy Individuals at Increased Risk of Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 74. 132–132. 1 indexed citations
7.
Kuemmerle‐Deschner, Jasmin, H. Hoffman, Philip N. Hawkins, et al.. (2015). SAT0524 Evaluation of Long-Term Safety and Effectiveness of Canakinumab Therapy in Patients with Cryopyrin-Associated Periodic Syndrome: Results from Beta-Confident Registry. Annals of the Rheumatic Diseases. 74. 850–850.
8.
Gabay, Cem, et al.. (2014). Biological agents in monotherapy for the treatment of rheumatoid arthritis. Swiss Medical Weekly. 144(1516). w13950–w13950. 19 indexed citations
9.
Adler, Scott, Dörte Huscher, Yannick Allanore, et al.. (2014). USE OF IMMUNOSUPPRESSANTS IN SSC PATIENTS WITH INTERSTITIAL LUNG DISEASE - RESULTS OF THE DESSCIPHER PROJECT OF THE EUSTAR GROUP.
10.
Hügle, Thomas, Philipp Schüetz, Thomas Daikeler, et al.. (2011). Late onset systematic sclerosis: A systematic survey of the eular scleroderma trials and research group database. 2 indexed citations
11.
Avouac, Jérôme, Jaap Fransen, U.A. Walker, et al.. (2010). Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Annals of the Rheumatic Diseases. 70(3). 476–481. 286 indexed citations
12.
Kremer, Heidemarie, Gabriele Arendt, N. H. Brockmeyer, et al.. (2009). HIV or HIV-Therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV. European journal of medical research. 14(4). 139–46. 15 indexed citations
13.
Hügle, Thomas, et al.. (2008). Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?. Annals of the Rheumatic Diseases. 68(1). 47–50. 20 indexed citations
14.
Greeve, Isabell, et al.. (2007). Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort. Acta Neurologica Scandinavica. 116(4). 207–210. 16 indexed citations
15.
Walker, U.A., Markus Uhl, Stefan M. Weiner, et al.. (2006). Analgesic and disease modifying effects of interferential current in psoriatic arthritis. Rheumatology International. 26(10). 904–907. 22 indexed citations
16.
Walker, U.A., et al.. (2001). »Katastrophaler SLE« mit Rosai-Dorfman-Sinushistiozytose - Erfolgreiche Behandlung mit Anti-CD20/Rituximab -. DMW - Deutsche Medizinische Wochenschrift. 126(37). 998–1001. 3 indexed citations
17.
Walker, U.A., et al.. (2001). »Katastrophaler SLE« mit Rosai-Dorfman-Sinushistiozytose. DMW - Deutsche Medizinische Wochenschrift. 126(37). 998–1001. 40 indexed citations
18.
Walker, U.A., et al.. (2001). ["Catastrophic systemic lupus erythematosus" with Rosai-Dorfman sinus histiocytosis. Successful treatment with anti-CD20/rutuximab].. DMW - Deutsche Medizinische Wochenschrift. 126(37). 998–1001. 36 indexed citations
19.
Jakob, Ernst, et al.. (2000). Patients with Fibromyalgia Benefit from Aerobic Endurance Exercise. Clinical Rheumatology. 19(4). 253–257. 81 indexed citations
20.
Jakob, Ernst, et al.. (2000). Patients with Fibromyalgia Benefit from Aerobic Endurance Exercise. Clinical Rheumatology. 19(4). 253–253. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca Matro Breakdown of academic impact, for papers by Gemma Lepri Breakdown of academic impact, for papers by A Hartkamp Breakdown of academic impact, for papers by Tim Holbrook Breakdown of academic impact, for papers by Peter Loughenbury Breakdown of academic impact, for papers by Brian R. Kaye Breakdown of academic impact, for papers by Rakan Bokhari Breakdown of academic impact, for papers by Darren G. Gregory Breakdown of academic impact, for papers by G R Struthers Breakdown of academic impact, for papers by Kunlawat Thadanipon
Rankless by CCL
2026